In‐Silico Exploration of the StreptomeDB Database for Potential Irreversible DprE1 Inhibitors toward Antitubercular Treatment
ChemistryOpen · 2025
DOI: 10.1002/open.202500237 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistryOpen, 2025. Verfasst von Doaa G M Mahmoud und 4 weiteren Autor:innen. Beteiligte Einrichtung: Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, 61519, Egypt. Hauptthemen laut MEDLINE: Antitubercular Agents, Alcohol Oxidoreductases, Enzyme Inhibitors, Bacterial Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Umm Al-Qura University.
Abstract (Originalsprache)
Tuberculosis (TB) is one of the most fatal infectious diseases. Decaprenylphosphoryl‐D‐ribose oxidase (DprE1), one of the key enzymes in the synthesis of arabinogalactan and lipoarabinomannan, has become a focal point for anti‐TB drug discovery. An investigation of the StreptomeDB database, an extensive collection of natural products from Streptomyces species, yielded 63 nitro‐containing compounds with strong potential as masked electrophiles for covalent inhibitors. The compounds are prepared and screened against DprE1. The reliability of AutoDock 4.2.6 software in predicting the covalent docking scores and poses of the DprE1 inhibitors is evaluated. StreptomeDB compounds exhibiting covalent docking scores lower than PBTZ169, the reference inhibitor, against DprE1 (calc. –7.8 kcal mol −1 ) are recognized and underwent molecular dynamics simulations, succeeded by estimations of MM‐GBSA binding energies. According to the MM‐GBSA results obtained after 300 ns MDS, hydroxythaxtomin A and lajollamycin B exhibited better binding affinities against DprE1 with values of –51.2 and –50.5 kcal mol −1 , respectively, compared to PBTZ169 (calc. –49.3 kcal mol −1 ). Post‐MD analyses are conducted to examine the stability and affinity of the identified StreptomeDB compounds with DprE1. Robust bioavailability and drug‐likeness characteristics are expected for the investigated StreptomeDB compounds. These findings unveiled promising inhibitory activity for hydroxythaxtomin A and lajollamycin B against DprE1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, 61519, Egypt.
- Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, Giza, 12622, Egypt.
- Department of Chemistry, Faculty of Science, Umm Al-Qura University, Makkah, 21955, Saudi Arabia.
- Department of Engineering, College of Engineering and Technology, University of Technology and Applied Sciences, Nizwa, 611, Sultanate of Oman.
- School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban, 4000, South Africa.
ORCID-Profile: Jabir H Al-Fahemi, Mahmoud A A Ibrahim
Förderung
- Umm Al-Qura University
Zitieren
APA
Mahmoud, D. G. M., Mekhemer, G. A. H., Hegazy, M. F., Al-Fahemi, J. H., & Ibrahim, M. A. A. (2025). In‐Silico Exploration of the StreptomeDB Database for Potential Irreversible DprE1 Inhibitors toward Antitubercular Treatment. ChemistryOpen. https://doi.org/10.1002/open.202500237
Vancouver
Mahmoud DGM, Mekhemer GAH, Hegazy MF, Al-Fahemi JH, Ibrahim MAA. In‐Silico Exploration of the StreptomeDB Database for Potential Irreversible DprE1 Inhibitors toward Antitubercular Treatment. ChemistryOpen. 2025. doi:10.1002/open.202500237
BibTeX
@article{Mahmoud2025,
author = {Mahmoud, Doaa G M and Mekhemer, Gamal A H and Hegazy, Mohamed-Elamir F and Al-Fahemi, Jabir H and Ibrahim, Mahmoud A A},
title = {In‐Silico Exploration of the StreptomeDB Database for Potential Irreversible DprE1 Inhibitors toward Antitubercular Treatment},
journal = {ChemistryOpen},
year = {2025},
doi = {10.1002/open.202500237}
}
EUVIMED